Introduction
The production of antimicrobial peptides (AMP) by multicellular organisms is the first and oldest innate defense mechanism discovered by biological evolution [1] . During a long co-evolution with pathogens challenging them, different species developed their own optimal solutions for hydrophobicity, amphipathicity and charge of their host defense peptides (HDPs) to maximize their toxic effect on microbes, mainly targeting their membranes [2] . The fact that HDPs are still used by the innate system of animals and plants as a rapidly mobilized first line of antibacterial defense, testifies to the generality, variety, and robustness of this particular defense mechanism.
As a rule, antimicrobial peptides are highly cationic, which is of course suitable for their interaction with bacterial cytoplasmic membrane, which has a high density of negative charges at its surface. Furthermore, metabolically active bacteria develop a strong, inward directed electric field, which favors insertion of cationic AMPs into the membrane. The production of a varied arsenal of defense peptides, with expression profiles characteristic of different physiological contexts and tissues, is doubtless the best solution nature found to provide us with a fast initial defense against pathogens [3] . This provides us with some rather interesting leads, but developing AMPs too similar to human HDPs might induce resistance development in pathogens, with crossresistance to natural HDPs on which they are based. Nonetheless, the supply of small molecule antibiotics for human use has almost dried up, with the development of fast spreading multidrug resistant bacteria, so that peptide antibiotics from different species are considered as an important source of potential lead compounds for medical applications. Given their nature, and recognized problems for systemic applications (low bioavailability, fast clearance, immunogenicity and a generally imperfect selectivity for bacterial cells) they are considered to be most suitable for topical uses, such as treatment of infected wounds, burns or diabetic foot ulcers [4] , as well as for the development of biomedical coating refractory to infection [5] .
In nature, HDPs seem to be used in a manner that prevents eliciting resistance, with a lot of flexibility, often in combination with other antibacterial agents and responses, so that bacteria are never stimulated to select for resistance mechanisms. This, and the well-documented multi-modal nature of their action (hitting multiple targets or having roles in different defense systems) [6] is one way in which flexibility has been encoded into their sequence from the very beginning. Secondly, it has often been observed that the evolution of HDPs is very rapid, in response to the positive selective pressure exerted by rapidly evolving pathogens [2] , and this is a further element of their flexibility. Finally, another way that HDPs ensure a high flexibility is inherent in their relatively small size and unfolded structures, which allows them to rapidly change conformation to adapt to, and maximize (or reduce) interactions with different microenvironments with quite different physical properties [7, 8] .
The separation of hydrophobic and polar or charged residues in different regions of their surface is the main characteristics of membrane-active helical antimicrobial peptides [9] . This ability is encoded in their sequence so that they present disordered structures in aqueous solution, that prevent unprofitable interactions with medium components, while they rapidly adopt some degree of regular amphipathic secondary structure on interaction with the anisotropic membrane interface [10] . Attempts have been made to express helical peptides' amphipathicity in a quantitative manner by using different definitions of the hydrophobic moment [11, 12] . Common, sequence-based definitions, are based on an unrealistic assumption that the whole peptide acquires a regular helical conformation [13] , which is not supported experimentally. Even in the presence of the strongly helix-inducing solvent TFE, helix forming peptides are estimated to have a significant non-helix content, particularly at the terminals where intermolecular Hbonding cannot occur, a phenomenon known as helix fraying [14] . In more physiological microenvironments, such as the membrane-water interface, there are three different compartments, the aqueous bulk solution, the hydrocarbon lipid layer, and the amphipathic interface region between them resulting from the phospholipid head-groups. To be membrane active, an AMP must be able to adjust its structure on its trajectory from the bulk solution to the membrane bilayer, and this adjustment goes both ways. When the peptide's concentration at membrane surface becomes high enough, the bilayer must also adjust to accommodate the peptides as new membrane components. This adaptation has its limits, and when a critical peptide concentration is reached, the bilayer structure becomes permeable to water and ions [15] [16] [17] . This eventually results in the death of a bacterial cell, which becomes unable to maintain membrane potentials and active ATPsynthesis in the presence of uncontrolled ion transport [18] .
In the published literature on AMPs design (see for example the review by Fjell et al. [19] ) it has been pointed out that substitution of proline or glycine, in central hinge region of some natural helical AMPs, with hydrophobic and helix forming residue, like leucine or alanine, resulted in a marked decreases in selectivity, as well as bactericidal activity [20] [21] [22] [23] [24] . It has been proposed that the presence of these residues favors a more flexible interaction of these peptides with anionic bacterial membranes, facilitating insertion process. This observation has prompted us to investigate if other types of central hinge regions developed through the evolution of helical AMPs, are possibly even more effective than proline or glycine in ensuring fast adaption of conformations in "surface-loving" peptides to the different physical properties of membrane interfaces. We decided to use the tandem turn repeat (TTR) pattern GVAKG-VAK characteristic of some ranatuerins from the skin secretions of ranid frogs. In membrane environments, these peptides adopt bent or kinked helical structures with two helices in the polypeptide region preceding the cyclic, C-terminal Rana-box segment [25] . In addition to allowing a flexible bending angle between two helical segments, the TTR motif in the middle of a peptide has the potential to form a 'Möbius-like' strip [26] , which allows not only helix bending but also rotation about its axis of the second helical segment with respect to the first. This provides an unparalleled opportunity for adjusting conformation of charged residues and of entire peptide to different types of membrane bilayers.
A broad-spectrum antibacterial activity is usually the design goal for AMPs, but very little is known about which peptide features code for activity against both Gram-negatives and Gram-positives. Our initial hypothesis was that incorporation of a dynamic flexibility motif in a peptide sequence already honed by evolution could achieve a re-configuration of its super-secondary structure to strengthen electrostatic and hydrophobic interaction with the very different cytoplasmic membrane of the two types of bacteria. Furthermore, this flexibility motif might allow the peptide to circumvent cell surface modifications characteristic of some multidrug resistant bacteria [27, 28] . In this work we present the design and molecular dynamics simulations (MD) for the FLEXible AMphipathic Peptide (flexampin), which has a wide-spectrum activity against Gram-negatives, Gram-positives, and multidrug resistant bacteria in low micromolar range, while at the same time being relatively innocuous, at bactericidal concentrations for human circulating blood cells and human fibroblasts.
Materials and methods

Chemicals
Acridine orange (AO), ethidium bromide (EtBr), histopaque, low melting point (LMP) and normal melting point (NMP) agarose were from Sigma (St Louis, USA). Synthetic flexampin, ranatuerin-2CSa without C-terminal Rana-box, and DiPGLa-H were obtained from GenicBio Limited (Shanghai, China) as > 98% pure and C-terminally amidated, with respective sequences: GIKKWVKGVAKGVAKDLAKKIL, GILSSFKGVAKGVAKDLAGKLLETLK, and KIAKVALKALKIAKVALKAL. Heparinized vacutainer tubes were from Becton Dickinson (Franklin Lakes, USA). All other reagents used were laboratory-grade chemicals from Kemika (Zagreb, Croatia).
Bacterial strains and antimicrobial activity assay
Standard laboratory strains used were from the American Type Culture Collection (ATCC, Rockville, MD, USA) of Gram-negatives Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Acinetobacter baumannii (ATCC 19606), and Klebsiella pneumoniae (ATCC 13883), and Gram-positive Staphylococcus aureus (ATCC 29213). Clinical isolates were obtained from the University Hospital Center, Split, Croatia. Antibiograms indicated that they are variously resistant to several classes of antibiotics (see Table S1 from Supplementary material [29] ). Additional clinical isolates of E. coli, A. baumannii, and S. aureus labeled with the number 2, were also isolated and characterized in the same hospital (Tables S1 and S2 in the Supplementary  material) .
Antimicrobial susceptibility testing on planktonic cells was performed using the microdilution method in 96-well microtiter plates as previously described [29] . Briefly, overnight bacterial cultures were resuspended in fresh Mueller Hinton (MH) medium and allowed to grow to the mid-exponential phase. Serial 2-fold dilutions of the peptide (64 μM to 0.0625 μM) were added to a final load of 5 × 10 5 CFU/ml in 100 μl total volume of medium per well. Challenged bacterial cultures were incubated for 18 h at 37°C. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of the peptide at which no visible bacterial growth was observed as a consensus of three independent experiments performed in triplicate. For the determination of minimum bactericidal concentration (MBC), 4 μl aliquots were taken from the wells corresponding to single, double and quadruple MIC, and then plated on MH agar plates. After incubation for 18 h at 37°C, the MBC values were recorded as concentrations causing ≥99.9% of killing of the initial inoculum, which contained about 2000 CFU.
Cytotoxicity on non-circulating human cells
Human skin primary fibroblasts were bought from Axol Bioscience LTD, GB. Cells were cultured in DMEM D5796 medium, supplemented with 10% (v/v) FBS, 1% Pen Strep (v/v) and maintained in a humidified incubator with 5% CO 2 at 37°C until they reached confluence. They were detached using trypsin-EDTA solution, subcultured in 96 well plates in 200 μl medium (7000 cells/well) and incubated overnight.
The toxicity of selected peptides was assessed by a standard MTT assay [30] . After overnight incubation, the medium was removed, and 100 μl of fresh medium was added to fibroblasts cell culture with increasing concentrations of peptides and incubated for 24 h at 37°C with 5% CO 2 . The medium was then removed, and 200 μl of fresh medium supplemented with 20 μl of MTT (5 mg/ml) solution was added and the suspension incubated for 4 h. The medium was removed, and 200 μl of DMSO was added to each well to dissolve the formazan crystals. Absorbance was measured at 595 nm with an EnSight Multimode Plate Reader (Perkin Elmer, Inc.). Experiments were performed in duplicate.
Cytotoxicity and genotoxicity on circulating human blood cells 2.4.1. Blood sampling and treatment
The effect of flexampin was evaluated in human peripheral blood leukocytes (HPBLs) obtained from two young healthy male donors. Subjects gave informed consent to participate in this study. The study was approved by the institutional Ethics Committee and observed the ethical principles of the Declaration of Helsinki. According to the questionnaire, which the donors completed, they had not been exposed to ionizing radiation for diagnostic or therapeutic purposes or to known genotoxic chemicals that might have interfered with the results of the testing for a year before blood sampling. Blood was drawn by antecubital venipuncture into heparinized vacutainers containing lithium heparin as anticoagulant under aseptic conditions. The aliquots of peptide solution were added to the whole blood samples during a 4 and 24 h period to make the final concentrations of 0, 1.56, 3.13, 6.25, 12.50, 25, 50 and 100 μM. In each experiment, a non-treated control was included.
Cell viability (cytotoxicity) assay
Cytotoxicity was determined by differential staining with AO/EtBr and by fluorescence microscopy [31] . Whole blood samples were exposed to increasing concentrations of flexampin (0, 1.5, 3, 6, 12, 25, 50 and 100 μM) for 4 and 24 h periods. After the treatment, HPBLs were isolated by histopaque density gradient centrifugation method. The slides were prepared by adding AO/EtBr (both diluted in phosphatebuffered saline, PBS) to HPBLs suspension in final concentration of 100 μg/ml (1:1; v/v). A total of 100 cells per repetition were examined with an epifluorescence microscope (Olympus BX51, Tokyo, Japan). Quantitative assessments were made by determining the percentage of live and dead cells. The nuclei of live cells emitted a green fluorescence while dead cells emitted red fluorescence.
Alkaline comet (SCGE) assay
The alkaline comet assay was carried out basically as described by Singh et al. [32] with minor modifications [33] . After exposure to flexampin (0, 1.5, 3, 6, 12, 25, 50 and 100 μM) the whole blood was mixed with 100 μl of 0.5% LMP agarose and added to fully frosted slides pre-coated with 0.6% NMP agarose. After solidifying, the slides were covered with 0.5% LMP agarose, and the cells were lysed (2.5 M NaCl, 100 mM EDTANa 2 , 10 mM Tris, 1% sodium sarcosinate, 1% Triton X-100, 10% dimethyl sulfoxide, pH 10) overnight at 4°C. After cell lysis, the slides were placed into alkaline solution (300 mM NaOH, 1 mM EDTANa 2 , pH 13) for 20 min at 4°C to allow DNA unwinding and subsequently electrophoresed for 20 min at 1 V/cm. Finally, the slides were neutralized in 0.4 M Tris buffer (pH 7.5) for 5 min 3 times, stained with EtBr (10 μg/ml) and analyzed at 250× magnification using an epifluorescence microscope (Zeiss, Göttingen, Germany) connected through a black and white camera to an image analysis system (Comet Assay II; Perceptive Instruments Ltd., Haverhill, Suffolk, UK). One hundred randomly captured comets from each slide were examined. The percent of tail DNA was used to measure the level of DNA damage.
Hemolysis of human erythrocytes
Fresh blood was obtained from a healthy male donor. Blood was stored in a tube containing EDTA at 4°C and used within 24 h. Before use, 1 ml of blood was centrifuged (400 g, 10 min) and supernatant was discarded. Then, 500 μl of cold PBS with EDTA (1 mM) was added to the tube, mixed gently and centrifuged (400 g, 20 min). Supernatant was discarded. Another 500 μl of cold PBS with EDTA (1 mM) was added to the blood, from which a dilution of 1% blood was made. Different peptide concentrations were prepared in PBS from 400 μM to 2 μM in 100 μl aliquots. The 100 μl of diluted blood was added to Eppendorf tubes containing peptide, which resulted in lowering the peptide concentration and the hRBC concentration by half. The final hRBC concentration was 0.5% (v/v) of the initial one. The suspension was incubated at 37°C for 1 h and then centrifuged at 10000 g for 5 min. A parallel incubation with 0.2% (v/v) Triton was performed to determine the absorbance value associated with 100% hemolysis, and with PBS alone to determine 0% hemolysis. After centrifugation, the supernatant was added to microtiter plate (180 μl) and the absorbance was measured at 450 nm. Each measurement was done in triplicate.
Statistical analysis
The χ 2 -test was used to evaluate the difference in the cell viability between control and exposed samples. Comet assay results were evaluated using Statistica 13.2 program package (Dell Inc., TX, USA). A logarithmic transformation was applied to normalize the distribution and equalize the variances of the comet assay data. Multiple comparisons between groups were done by means of ANOVA on log-transformed data. Post-hoc analyses of differences were done by Scheffé test. Data were considered statistically significant at P < 0.05.
Molecular dynamics simulations
Molecular dynamics simulations were carried out using Gromacs 5.0.7 [34] for the peptide placed in water or TFE:water solution, and for the peptide interacting with the neutral lipid-environment or anionic lipid membrane. The GROMOS54a7 force field [35] was used to describe the peptide, phosphocholine (PC) lipids [36] , TFE [37] , and the SPC/E model for water [38] . As for the lipids comprising the anionic membrane, the topology files for POPE were taken from Prof. P. Tieleman's website (http://wcm.ucalgary.ca/tieleman/downloads) and for POPG from Prof. M. Karttunen's SoftSim website (http://www.softsimu. net/downloads.shtml) [39] . The initial peptide structure was α-helical, as predicted by the QUARK protein structure predictor [40, 41] . The structures of zwitterionic lipids DLPC, DEPC (diC22:1c13) and DHPC were provided by Prof. A. Mark's laboratory and the ATB builder [42] .
The PC bilayers were built by placing the membrane normal along the z-axis, with around 128 lipids in each leaflet and water molecules added to keep the water to lipid ratio above 40:1. Using local programs, we ensured that the water molecules are removed from the membrane hydrophobic core. The simulation runs were at least 20 ns. The DHPC micelle was generated starting from a random mixture of 62 lipids placed in a cubic box with 10 nm size and solvated with a large excess of water molecules. The system was simulated for 60 ns with micelle appearing after 30 ns. The configuration reached after 60 ns was used as the starting micelle for the simulations with the peptide.
The simulations for the equilibration of PC bilayers were carried out using Gromacs 3.3.3 [43] as follows: isobaric-isothermal NpT ensemble conditions T = 303 K and p = 1 bar were kept using the Berendsen algorithm [44] with the time constant 0.1 ps for temperature and 1.0 ps for pressure couplings, while compressibility was set to 4.6 × 10 −5 bar with the time step of 4 fs and LINCS constraint-algorithm [45] . The reaction field method [46] was used for the electrostatics, and the relative dielectric permittivity of the medium outside the cutoff of 1.4 nm was set to 62 [47] . The same cut-of 1.4 nm was used for the truncation of the short range interactions. The DHPC micelle was generated using the same simulation parameters except for the temperature, which was kept at T = 298 K.
The coordinates for POPE:POPG leaflets (end of the 100 ns simulation) with 96 POPEs, 32 POPGs (and the equal numbers of L-and Dconfigurations for the chiral center of POPG), and 3623 water molecules were downloaded from Prof. M. Karttunen's SoftSim website (http://www.softsimu.net/downloads.shtml) [39, 48] . This system was duplicated and hydrated in order to have similar sizes for each membrane, and equilibrated for an additional 20 ns. The simulations details were the same as for the peptide-lipid systems.
We performed 8 different simulation experiments (Table 1) , which comprised 20 simulation cases, for a total simulation time of 2.58 μs. The first experiment was for the flexampin immersed in the octahedral box with water molecules, and the second for the peptide placed in the 30% (v/v) solution of TFE in water (which corresponded to about 10% of the molar solution). In the third and fourth experiment the peptide was placed inside the hydrophobic region of the hydrated and equilibrated DLPC bilayer and DEPC bilayer, respectively, with perpendicular orientation to membrane surfaces, by using the InflateGRO methodology [49] . For the fifth experiment, the peptide was also immersed deep inside and perpendicularly to the POPE:POPG bilayer using the InflateGRO2 program [50] . In the sixth and seventh experiment, we tested the interaction of the peptide with planar membrane surfaces.
The peptide was placed in the water, 1.2 nm above and parallel or slightly inclined with respect to the surface of the DLPC and POPE:-POPG membrane respectively. For the eighth experiment, the peptide was placed in the water layer at a distance of 2.8 nm from the preformed DHPC micelle. For cases of peptide added above phospholipid membrane (the sixth and seventh experiment) we performed three simulations, each lasting 200 ns. Different initial conditions were set up for these three simulations: The simulations I and II started with initial peptide orientation parallel to membrane surface, but different velocity distributions, while the simulation III started with the peptide being inclined for 10°with respect to membrane surface and with initial velocity distributions identical to those we used for the simulation I.
Test runs, lasting 20-40 ns, were also performed for other cases. In the case of the peptide placed in the membrane (third, fourth and fifth experiment) the initial configuration was built by putting the peptide in the same position as in 200 ns run and by using different velocity distribution. Also in another test run the starting conditions were the same velocity distribution (as in the 200 ns run) and inverted position of the peptide keeping the perpendicular orientation and placing the Nterminal nearby the top layer of the membrane surface. In the case of the peptide interacting with DHPC micelle starting configurations for the test runs were: different velocity distributions and the change of location with respect to closest micelle phospholipids (the eighth experiment). The molecular composition for each experiment is presented in Table 1 .
The charges on peptide were chosen as appropriate for pH = 7, the N-terminal was positively charged and the C-terminal was amidated. Counterions were added to neutralize the peptide-lipid systems; Cl − atoms in the case of solvents and neutral membranes, and both Cl − and Na + for the case of anionic membrane. The simulation set up included the equilibration of systems using the temperature annealing procedure, and production runs in isothermal isobaric (constant NpT) ensemble where T = 310 K was kept using the modified Berendsen thermostat [44] with 0.1 ps time constant for the temperature, and the pressure of p = 1 bar was maintained using the Parrinello-Rahman barostat [51] with a 2.0 ps time constant. Compressibility was 4.6 × 10 −5 bar. During equilibration, the motion of the peptide was restricted by the use of the position restraint option. The leap-frog integrator time step was fixed at 2 fs [52] and the bonds were handled by the LINCS option [45] . Particle-mesh-Ewald method was used for the calculation of the electrostatic interaction [53] and the van der Waals cutoff was set to 1.0 nm.
The analyses were done using gromacs utilities (http://www. gromacs.org/), i.e. gmx helix, gmx bundle, gmx helixorient, gmx density, gmx mindist, and the time dependence of the secondary structure with the Dictionary of Secondary Structure of Proteins (DSSP) program [54] . In particular, we calculated changes in the characteristic helical radius, rise and twist for each residue, the kink angle between the helices, and the tilt angle as the inclination with respect to the initial perpendicular line spanning two membrane surfaces. The peptide's interaction with the membrane surface was validated through matching the density profiles of the peptide, lysine residues and phosphate atoms, and calculation of the minimum distances and number of contacts of each flexampin's lysine and phosphate atoms. The 3D hydrophobic moment was found using the server based on Reißer et al. calculations (http://www.ibg.kit.edu/HM/?page=pdb) [12] . In membrane environments dielectric permittivity values were obtained from Leermakers et al. (Fig. 3e from [55] ) using a GetData Graph Digitizer v.2.26 and Auto-tracing option. First, z-coordinates of membrane phosphate atoms were averaged so that the middle of the lipid bilayer was found. Secondly, for each amino acid, the closest dielectric permittivity value was assigned based on its distance from the middle plane, followed by averaging permittivity values for the entire peptide. This averaged permittivity value for the corresponding peptide conformation was submitted to the server and used for the 3D HM calculations as described in [12] . Pqr files obtained as output from the server [56] were used to calculate the dipole moment vector, so that vector origin is at the charges-weighted center of the peptide.
Visualization was done using PyMOL [57] except for Fig. 6 , which was created in VMD v.1.9.4a9 [58] .
Results
Peptide design
The need for hydrophobic matching of peptide length and conformation to hydrophobic core properties has been well established in the case of antimicrobial peptides [59] . Our additional design goal in this work was to ensure that peptide amphipathicity could self-adjust to match the interface amphipathicity of different membrane bilayers. In order to construct a broad spectrum peptide antibiotic, we concluded that the best strategy was to find a good compromise between the need for high flexibility and an optimal amphipathic matching ability in the peptide structure, with a requirement for bendable clusters of positive charges that can stimulate peptide attachment to the bacterial membrane. A useful design feature seemed to be that of having a flexible central motif joining two amphipathic helical stretches, which could facilitate changes in the peptide's overall shape from a straight, rod-like conformation to one more like a boomerang, or a V-shape, L-shape or hairpin-like structure, in this or a time-reversed direction. It was not clear, however, if there is any single type of turn-prone structure that can be placed in a central peptide position, which could allow interaction with membrane interface in such a flexible manner.
We decided to use the GVAKGVAK sequential tandem motif, found in a central pre-Rana-box position of the frog AMPs ranatuerins 2CSa (V9GZ92), 2La (P82828), 2Lb (P82829), 2Ma [60] , 2AUa [61] , 2PRa, 2PRb and 2PRd [62] . This motif was also found at the transcript level in Rana sierrae ranatuerin 2SRa (J9RZ39) and Pseudacris regilla ranatuerin 2PRa (J9RRY7), although the Ranoidea and Hyloidea superfamilies diverged > 100 million years ago [63] . It appears that despite the accelerated evolution of anuran AMPs, this central pattern was conserved indicating its structural and functional importance. About 20 ranatuerins from the DADP database [64] , including several with the GVAKGVAK central motif, have antifungal in addition to antibacterial activity, a defense feature known to be important for frogs [62] .
In the case of shortened ranatuerin-2CSa devoid of a C-terminal Rana-box, the sequence of interest is GILSSFKGVAKGVAKDLAGKLLE-TLK. Our designed peptide, named flexampin, has the GIKKWVKGV-AKGVAKDLAKKIL sequence with identical central tandem-turn pattern (underlined) forming the half Möbius strip when the NMR structure of ranatuerin-2CSa [25] is examined together with hydrogen bonds in the central region [26] . A total of six residues in a bold font are introduced as amino acid substitutions.
We used a combination of home-made algorithms and expert knowledge to introduce these substitutions. The algorithms Mutator (http://split4.pmfst.hr/mutator/), and MIC-predictor (http:// splitbioinf.pmfst.hr/micpredictor/) were recently described [26, 65] . Version SPLIT 3.5 [66] of the SPLIT algorithm (http://split4.pmfst.hr/ split/) was also used for AMPs analysis [67] . The goal was to construct a shorter peptide with an increased positive charge suitably positioned with respect to the hydrophobic residues in such a way as to achieve an increased hydrophobic moment of both helical arms.
Changes in the hydrophobic moment of the peptide helical arms during the design procedure can be seen in Table 2 as sequence location and the maximal value of modified hydrophobic moment calculated by SPLIT 3.5 software. Modifications of Eisenberg's hydrophobic moment (HM) enabled calculations of moment profile alongside the peptide sequence by looking for a helix twist angle giving the maximal moment for each sliding window of three residues. This method of HM calculations is better in finding surface-attached helices in membrane proteins [68] , and suitable for our analysis on how HM changes in different peptide segments after amino acid substitutions. It produced the HM profile, named INDA, as a SPLIT 3.5 numerical output. Any software tool for calculating the HM profile is better than reporting a low HM for the complete sequence in an assumed ideal α-helical structure, an artifact for peptides like flexampin which contains several different domains with the ability to form different secondary structures, each having its own high HM. For instance, we also used the HeliQuest online tool http://heliquest.ipmc.cnrs.fr/ [69] to calculate hydrophobic moments of peptide N and C-terminal half in different helical conformations by using the Fauchère and Pliska hydrophobicity scale [70] . HeliQuest reported a moderate HM for the peptide in the α-helix conformation, but confirmed that better balance is achieved between increased α-helix hydrophobic moments of helical arms at the end of the design procedure and also suggested that the 3 11 and π helix conformation may be possible within flexampin (Table S3 ). The SPLIT 3.5 algorithm concurred in finding that the sequence profile with maximal hydrophobic moments for each amino acid triplet can be realized with Table 2 asked for reasoning how to overcome software limitations. Some amino acid substitutions, such as S(4)V(5) to K(4)W (5) , and G19 to K19 were introduced manually to increase net charge, amphipathicity and buriability of helical arms. While it was not possible to improve the prediction for each activity parameter in each design step, we were satisfied that subsequent steps achieved better overall balance among amphipathicity of helical arms, predicted selectivity index SI [65] , and minimal inhibitory concentration (MIC) [26] . We verified that the composite index CI = I1 × I2 × SI/MIC increased from 29 to 352 going from the second to the fifth row of Table 2 . Limitations of the MIC-predictor were bridged by adding the Rana-box CKITGC from the ranatuerin-2CSa. The CAMP R3 AMP predictor http://www.camp.bicnirrh.res.in/predict/ predicted only a slight increase in AMP probability from 0.96 to 0.99 (support vector machine results) with each design step.
The BLASTP search at https://blast.ncbi.nlm.nih.gov/ found only peptide or protein fragments with < 70% identity to flexampin. As expected, ranateurin-2CSa was the most similar with an E value slightly higher than 0.01. Some other antimicrobial ranatuerins-2 were also similar due to an identical central pattern GVAKGVAK or similar patterns GLAKGVAK (ranatuerin 2BYa (P84114)) and GIAKGVAK (ranatuerin 2DR (J9RZ47_9NEOB)). All of these patterns are amphipathic and contain two overlapping "small motifs" [GA]-X-X-X-[GA] expected to promote the membrane association of enough hydrophobic helices in a membrane environment [71] or at the membrane surface, but not in bulk water where lysines and hydrophobic residues will prefer contacts with water molecules and with each other in a collapsed monomer, respectively. Altogether, flexampin contains three regular 5-mer motifs [GA]-X-X-X-[GA] with [GA] being either glycine or alanine, which may promote their self-association, dimerization or higher oligomerization states at membrane surface or in the membrane's interior [72] .
With its length of 22 residues, flexampin in helical or partially helical conformation can easily span the width of a membrane bilayer. Also, due to the flexible nature of close to 10 central residues, which should be capable to turn, twist and change polypeptide chain conformation and length, our final design choice is expected to achieve hydrophobic matching for different biological membranes, which is important for biological activity [59] . We assumed that the amphiphilic central region has already been honed through biological evolution to destabilize helical conformation and decrease peptide aggregation in the water phase, while promoting the formation of adaptable helixturn-helix amphipathic conformation for membrane-bound peptide associations with strong peptide-phospholipid interactions and membrane destabilization in cases of bacterial-like anionic membranes.
The described design method can be easily modified starting with the same approach of using an unchanged central hinge region, for instance by replacing lysine with arginine pairs at both helical arms of flexampin. Arginines often increase membrane translocation and antibacterial activity [73] and are better than lysines in establishing electrostatic and hydrogen bonding with anionic components of bacterial membranes [74] . The presence of Trp in the fifth position should allow spectroscopic investigation of differences seen from MD simulations between N-terminal helix immersion of flexampin into zwitterionic and anionic membranes with concomitant conformational changes (see the MD simulations section 3.5). The presence of Asp at the 16th position should facilitate shifts in helix topography when Asp residues are ionized [75] .
Antibacterial activity results
Flexampin has a strong and broad spectrum of bactericidal activity against all of the tested bacterial strains including the multidrug resistant clinically isolated ones (Table 3 ). Its antibacterial concentration is considerably lower in the case of the planktonic mode of growth than for peptides ranatuerin-2CSa, and shortened ranatuerin-2CSa without Rana-box CKITGC, from which it was derived. Most other natural or man-made helical antimicrobial peptides derived from anuran AMPs have weaker activity (Table S4 ). The sub-micromolar flexampin concentration already caused serious damage to E. coli ATCC 25922 membranes as confirmed by preliminary atomic force microscopy experiments (results not shown). From a therapeutic perspective, it is interesting to note that this peptide does not distinguish among standard and multidrug resistant A. baumannii strains. It kills all such tested strains when applied within a concentration range of 0.5 to 1.0 μM. Both resistant strains are resistant to aminoglycosides and may have decreased outer membrane permeability [28] (Tables S1 and S2) . For other in vitro tested strains, including multidrug resistant clinical isolates, flexampin antibacterial activity ranges from 0.5 to 4 μM, which are better MIC values from those obtained against the same strains with peptide antibiotics DiPGLa-H and kiadin-1, whose activity we tested previously under same conditions [29, 76] . The DiPGLa-H peptide was used as the internal control while flexampin activity was tested, and it displayed almost the same antibacterial activity (MIC = 1.6 μM) as previously measured (MIC = 1.5 μM) in two different laboratories [29, 76] . Fig. 1 illustrates the degree of hemolytic and toxic activity for human erythrocytes and for human fibroblasts, when tested during incubation with either flexampin or the initial peptide for flexampin design i.e. the shortened ranatuerin-2CSa without C-terminal Rana-box. Obtained results are similar for both peptides but different cell types exhibited different reactions. With respect to erythrocytes hemolysis, estimated HC 50 is higher than 200 μM for both peptides. The HC 50 concentrations > 200 μM are usually regarded as the sign of peptide low toxicity to red blood cells. The characteristic feature in the case of flexampin is its limited hemolytic activity (approximately 15%) even at 10 times lower peptide concentration of 20 μM, and a slow rise in concentrations needed to destroy > 40% of erythrocytes.
Hemolytic and cytotoxic activity on human erythrocytes and fibroblasts
For fibroblasts from the human skin we have decided to keep 10% FBS for cell growth despite the fact that it might slightly interfere with peptide activity, because it corresponds to more natural growth conditions for cells. The apparently low concentration of IC 50 = 30 μM (for flexampin) or IC 50 = 60 μM for its parent peptide for killing 50% of cells may be due to the necessarily small number of fibroblasts (about ten thousand) incubated with flexampin, because surface density of peptides is of crucial importance for their membrane-perturbing activity [15] and it can be easily calculated that the peptide to phospholipid ratio is considerably higher for fibroblasts (despite their greater size) than for much more numerous erythrocytes. Twenty times longer incubation time of fibroblasts than erythrocytes may have also contributed to lower IC 50 for fibroblasts. For both cell types, the selectivity index has a high value of SI = HC50 / MIC(E. coli) = 670, or SI = IC 50 (fibroblasts) / MIC(E. coli) = 100. However, since we incubated fibroblasts with peptides in the presence of the media containing the FBS serum some percentage of peptides may have ended bound to FBS leading to an overestimate for the IC 50 .
The Table S4 ranks peptides according to their selectivity index (SI). It illustrates the significant advantage of flexampin with respect to: its natural parent peptide ranatuerin-2CSa, b) ranatuerin-2CSa without its Rana-box i.e. the initial peptide sequence from which we started the flexampin design, c) natural anuran AMPs with highest SI, and d) other anuran-like peptides designed by our group (DJ), and by other research groups. The flexampin activity has been compared between healthy human erythrocytes and standard sensitive strains of E. coli (the HC 50 / MIC ratio; see highlighted SI values in the fourth column of Table S4 ).
Evaluation of cyto/genotoxic potential in human peripheral blood leukocytes
A dose-and time-dependent cytotoxic activity of flexampin was observed in HPBLs after the treatment ( Fig. 2A) . For examined exposure periods of 4 and 24 h, the IC 50 (the concentration that reduces the viability of treated cells to 50%) value was above 100 μM. Cell viability dropped down to 70.99 ± 7.16% after 4 h and to 61.45 ± 7.44% after 24 h of exposure for the highest concentration tested. A significant decrease in HPBL viability was noted at peptide concentrations equal to or > 12.5 and 6.25 μM after 4 and 24 h exposure, respectively. The IC 50 above 100 μM is considered to be in acceptable range for conducting further genotoxic analysis [77] as it is important to evaluate genotoxic potential at non-toxic concentrations to avoid false positive/negative results due to cytotoxicity and not genotoxicity.
For genotoxicity assessment a whole blood was exposed to flexampin for 4 and 24 h and the DNA damage in HPBLs was determined with the alkaline comet assay. There were no statistically significant differences in the amount of DNA strand breaks compared to the corresponding control samples (Fig. 2B) .
For comparison, the cytotoxicity and genotoxicity observed in HPBLs is presented in Fig. S1 for flexampin, colistin, melittin, DiPGLa-H, kiadin-1 and kiadin-2.
Molecular dynamics simulations in different environments
Through MD simulations, we tested how the peptide conformation changes during 200 ns (Figs. 3, 4 and 5) , when an α-helical monomer predicted by the QUARK tool [40, 41] is initially put into different environments and molecular compositions ( Table 1) . Three different initial conditions were used for simulating interactions between peptide and phospholipid systems ( Table 1 and Figs. 3, S2, S3 ).
Peptide placed in water or nonpolar environments
The top panel in the Fig. 3 shows the time evolution of secondary structures for flexampin sequence segments in a) membrane-mimicking trifluoroethanol-water solvent (TFE:water), and in e) water. In the TFE:water solvent, the α-helical structure is highly favored with 81% of residues being in that conformation ( Table 1 and Fig. 3a ). The fraying of the peptide's ending [14] is present, which reduces peptide length from the initial 3.48 nm to the final 3.33 nm. The central TTR motif did not exhibit its propensity to form turns. Either the simulation time was not long enough or the stabilization with the helix-promoting TFE solvent molecules was too strong. For this short peptide placed in pure water, unfolding was expected and observed (Fig. 3e) . Unfolding is predominantly seen in its N-terminal half, while the C-terminal helix maintained its shortened helical-like conformation for the duration of the simulation. Electrostatic interactions caused by the presence of aspartate and lysine residues in the peptide C-terminal may have helped to maintain a helical-like structure there.
For the peptide inside the DLPC membrane, the peptide endings are buried inside polar head regions of PC molecules when the helical monomer is initially positioned perpendicularly to bilayer surfaces ( Fig. 4 top panel) . Due to electrostatic interactions with polar head groups, the effect of helix fraying at helix terminals is less pronounced than in the TFE:water solvent (Fig. 3b, and Table 1 ), but the inherent instability of the central GVAKGVAK segment is now clearly seen, however in a curious manner as the dynamic shifting of sequence location for the turn, which moves from residues 9-12 to residues 12-14. This dynamic process reflects the bending of the peptide until it forms the L shape with the first helix extending several polar residues toward one membrane interface, while the C-terminal helix is attached with its polar residues to the other membrane interface in an almost horizontal position with respect to the membrane surface ( Fig. 4 top panel snapshots after 20 and 200 ns simulation). Similar findings are also observed in additional simulations (Fig. S2) .
Peptide conformational adaptations can be also seen as the tilt of the peptide with respect to an initial perpendicular line spanning two membrane surfaces, and bending between two peptide helices determined by the kink angle ( Figs. 4 and S4) . At the end of the MD simulation, the flexampin structure adapts to the shorter width of the DLPC bilayer by forming the tilt angle~40°and the kink angle~70° (  Fig. S4) . The most noticeable changes in helicity are for Gly12 and Val13 from the second GVAK motif, where the twist angle is increased to~120° (Fig. S5) .
To check if peptide bending is due to a hydrophobic mismatch [59] and examine how flexampin adapts to the larger thickness of the hydrophobic region, we also used the DEPC bilayer with 22-carbon-atomslong fatty acid tails (instead of 12 carbon atoms as in the case of DLPC).
Conformational change starts again inside the GVAKGVAK segment (at the V13) as the transient turn in the DSSP plot (see Fig. 3d ). However, the peptide preserves α-helicity to a high degree (85%, Table 1), with the amphipathic distribution of residues similar to the one observed in the case of the DLPC bilayer. The lysines in the C-terminal helix are rotated to face the polar region of the membrane (Fig. 4 lower panel,  left) , while placing the hydrophobic residues near the fatty acid tails. Flexampin adapts its structure better to a wider bilayer, where it forms a smaller twist angle of~106°for Gly12 and Val13 residues in the central bended region, leading to a smaller kink and tilt angle of~40°a nd~35°respectively, at the end of the simulation run ( Figs. 4, S4, S5) . The peptide inside the anionic mixture of phospholipids POPE:POPG (imitating bacterial phospholipids) assumes an oblique helical-like conformation ( Fig. 4 lower panel, right) preserving the 83% (v/v) TFE:water mixture, b) in the hydrophobic core of the DLPC bilayer, c) in the hydrophobic core of the POPE:POPG bilayer, d) in the hydrophobic core of the DEPC bilayer, e) in pure water, f) on the top of the planer DLPC bilayer, g) on the top of the planer POPE:POPG bilayer, h) within the neighborhood of DHPC micelles. The peptide starting structure was a helical structure as produced by the Quark tool. The simulations with different initial conditions for the peptide above the membrane surface (the simulations II and III) are shown in Fig. S3 . The color code below the figure is added to distinguish the evolution of different secondary structures, as accessed by the DSSP plots. The flexampin residues at the y-axis with underlined central TTR motif G 8 Fig. 3c ). Such conformation is typical for many natural helical antimicrobial peptides and the slight degree of hydrophobic mismatch they cause while entering deeper into bacterial membrane [78] . The kink angle between the two helices is~30°and the peptide axis has a tilt angle of~30°at the end of the 200 ns simulation (Fig. 4, lower panel, right; Fig. S4 ). The distortion of the α-helical structure is centered at the bend-forming residues Lys11 and Gly12 of the GVAK 11 G 12 VAK motif exhibiting a twist angle of~80° (  Fig. S5) . The characteristic conformational adaptation of flexampin to the anionic membrane bilayer is the counterclockwise rotation of the second helix with respect to first helix (Fig. S6 ). For neutral PC bilayers, we observed no cumulative rotation of the second helix with respect to the first helix during the 200 ns of simulation runs.
In contrast with simulations in the TFE:water solvent, the central TTR motif shows its potential for flexibility in membrane bilayers. We suggest the connection between the two new effects we saw in the bilayer environment, lesser fraying of helical ends and much more pronounced peptide bending and twisting. Polar head groups of phospholipids interact with charged or partially polar residues (such as tryptophan) near peptide termini enforcing helical cap interactions and adaptation to bilayer properties by bending of the polypeptide chain. The central GVAKGVAK structure facilitates bending and twisting until an optimal super-secondary structure is reached. It should be possible to get experimental verifications by using the NMR spectroscopy and a similar setup, as was already done for flexampin's natural parent, the ranatuerin-2CSa [25] .
The binding of the peptide to phospholipid systems
Placing the peptide inside the membrane bilayer helped in discovering the peptide's ability to adapt to the eukaryotic or prokaryotic type membrane, but up to now we did not consider a more realistic situation in which the peptide would need to first reach the external membrane surface. We shall show here that approaching the membrane surface, flexampin reveals even greater variability of its spontaneously formed super-secondary structures.
We first considered the peptide interaction with the DLPC membrane with the initial conditions set up for the simulation I ( Fig. 3 and Table 1 ). The unfolding is observed for the peptide placed near the membrane surface ( Figs. 3f and 5a, b, c) , and it is greater for the Nterminal helix but less pronounced than for flexampin placed in pure water (Fig. 3e ). As shown in Fig. 3f , coils, turns and bends appear early through simulation for residues V6 to A10 from the N-terminal half of the peptide sequence, while peptide approaches and partially enters among polar head groups of the membrane surface. It assumes a Ushape with its two terminal arms as less (C-terminal) and more (Nterminal) deformed short helices forming a very large mutual kink angle (~140°, Figs. 5c and S4 ). This analysis also revealed the crucial role of the central TTR pattern in facilitating peptide conformational changes while entering in the interface region first with its N-terminal. Similar findings are also observed in the simulations II and III as shown in the Figs. S3 and S4 from the Supplementary material. Large kink angles between 130°and 150°for the last 100 ns of these simulations are caused by turning and twisting of the central GVAKGVAK segment, the dynamics which favors self-interactions between helical-like peptide arms over stronger interactions with phospholipid polar heads.
The binding of the peptide to the anionic membrane exhibited more variable structuring in different simulations. In the first simulation case, the peptide attaches its N-terminal to the membrane surface, and subsequently its C-terminal too (Figs. 3g and 5d ) with arms of its V-shape structure forming the kink angle~70° (Fig. S4) , while their amphipathicity adapts to the highly amphipathic anionic membrane layer. In repeated simulations with a different velocity distribution (simulation II) or with a slight change in the initial peptide inclination with respect to the membrane surface (simulation III), the structures are more elongated (Fig. 5e and f) , and the kink angles are considerably smaller (~30°or less degrees, Fig. S4 ). Also, the snapshots of the peptide conformation at the end of the simulation time (Fig. 5d ,e and f), presents the helical-like structure for both N-and C-terminal heptad segments attached to the anionic surface, although the assigned properties for the N-terminal segment in the case of simulation I and II are bend and turn structure. The preservation of peptide elongated helixlike shape, enables stronger binding to the membrane surface, an increase of the overall peptide amphipathicity (Table 4) , and supports deeper entrance into the surface layer of the anionic membrane ( Fig. 5e  and f) . At the end of the third simulation the peptide becomes associated with the membrane surface as an almost perfect helix (Figs. 5f and S3). Strong electrostatic interactions might be the reason for the preservation of the initial helical structure, but extending hydrophobic residues toward bulk water does not ensure longer term stability, except in the case when peptide dimmers are formed with interacting hydrophobic helical faces making use of three small flexampin motifs (see Peptide design section). However, examining the potential for the formation of peptide dimmers or oligomers is beyond the scope of this paper.
The analysis of all simulation cases showed that peptide Table 1 for initial conditions used in simulations I, II, and III.
approaching the neutral membrane adopts the more globular structure, where the central segment is the more distant from the membrane surface, while in the case of anionic membrane its shape is more elongated and closer to the membrane surface, indicating stronger interaction with the anionic membrane. The small, but an important feature observed for the TTR structuring further illustrates the difference in peptide's interaction with neutral and anionic membrane ( Fig. 3  and S3 ). The coil or disordered region (with the white space color code) emerges very quickly (in < 10 ns) and remains persistent for all of three simulations above neutral DLPC membrane. It enables the establishment of intermolecular interactions, which maintain a partially collapsed hairpin-like structure above the DLPC membrane even after the closest approach to that membrane (Fig. 5c ). The final flexampin structure close the end of 200 ns simulations (all three simulations) is devoid of disordered structure for peptide above anionic POPE:POPG membrane.
Considering phospholipid phosphate atoms as relevant for the location of membrane surface we found better matching of the average positions of the peptide and its lysine residues to the location of membrane surface in the case of the anionic membrane (Fig. S7) . The time-dependent minimum distances between lysines and phosphates ( Fig. S8 ), also exhibited stronger overlapping for the anionic membrane. Furthermore, many more contacts are observed between the phosphate atoms of anionic membrane and lysines then in the case of the neutral membrane (Fig. S9 ). The lysine 11 from the GVAK 11 GVAK 15 segment remains the furthest from membrane phospholipids and with the smallest number of contacts, except in the simulation III for the peptide above the anionic membrane. It is mostly free, together with several other residues from that segment, to determine the final peptide shape during the crucial stage of peptide-membrane interaction. This supports other evidence that the central segment acts as the facilitator or inhibitor, which either enables or inhibits the peptide arms to achieve better binding to the membrane surface depending on net surface charge.
Finally, to investigate the structural realization of flexampin in interaction with the curved lipid-environment, we used DHPC micelle (Figs. 3h, 5g and h, S2, S4) . The results show that in this case too, the most flexible segment is the TTR motif. The N-terminal segment has a less stable structure, while the C-terminal segment preserves more αhelicity. Both segments use a central flexible TTR segment for adaptation to the heterogeneous environment of the micelle, such that the Cterminal and N-terminal lysines interact with polar head groups and bulk water, while hydrophobic residues take advantage of the peptide concave surface to become more buried in the micelle. The U-like peptide shape with a hydrophobic interior surface is similar to the same shape peptide adopts near neutral planar bilayer (Fig. 5b and c) . The micelle is a highly fluctuating system, so it is not surprising that the additional simulation experiments (Fig. S2 ) resulted in a different structuring, but the general features persist, i.e. the flexibility of the central peptide region and the amphipathicity of the peptide arms connected by the bending region.
MD simulations and dielectric profile used for moments calculations
We also calculated the 3D hydrophobic moment using the 3D HM calculator [12] , as well as electrostatic dipole moment vector (Table 4 ) using a local script and an input pqr file previously obtained as a part of 3D-HM server results. When four peptide segments are considered separately as first seven AAs, first GVAG segment, second GVAK segment, and last seven residues, their contribution to 3D HM is similar, despite different size and different conformations after interaction with the membrane surface (not shown). Dipole moments (in eÅ) were similar for the initial helical peptide conformation above or inside the membrane in all simulations (290 to 320 D when converted to Debeye units). Solvent screening is expected to decrease dipole moments by a similar amount in the case of peptide positioned similarly with respect to the surface of the neutral or anionic membrane. When solvent screening was taken into account [79] , much more realistic values of approximately 4 D above the membrane and 12 D for the helical peptide inside the membrane were found at the start of different simulations. Similarly, due to lesser solvent screening, the 3D HM, which was in the range 12-14 for the initial helical structure above the membrane, increased to the range 33-35 for the helical peptide immersed perpendicularly in the bilayer (in kTÅ/e units). At the end of 200 ns simulations, the presented results (Table 4 ) are for conformations achieved in Fig. 6 . 3D hydrophobic moment (magenta arrow) and electrostatic dipole moment vector (green arrow) were calculated for the flexampin conformation achieved after 200 ns of MD simulations for peptide approaching the A) neutral (DLPC) and B) anionic (POPE:POPG) membrane surface as described in Fig. 5 for corresponding simulations ( Fig. 5c and f, respectively) and in Table 4 . Right parts of A and B: Electrostatic potential on the solvent-accessible peptide surface as obtained through 3D HM calculator output [12] . different environments. Approximate values in Debye units for the effective dipole moment were obtained by multiplication of the reported value with the conversion factor and the corresponding value for inverse dielectric constant from the Table 4 .
The elongated peptide structure obtained in simulations for the peptide positioned above the anionic (POPE:POPG) bilayer is associated with a remarkable increase of the dipole moment and of the 3D HM for entire peptide with respect to moments of globular-like peptide structure at the surface of the neutral (DLPC) bilayer in corresponding simulations with the same initial conditions ( Table 4 ). The inclination of both moments toward the peptide N-terminal and toward the membrane interior is much more prominent for the peptide that initiates interaction with the anionic bilayer (Fig. 6) . In a hypothetical situation when the flexampin monomer succeeds to completely enter in a nearperpendicular orientation toward the membrane anionic surface (the simulation snapshot Fig. 4 bottom right) , its 3D HM more than doubles again ( Table 4 ). Due to the decrease in solvent screening by about three times inside the membrane, the effective dipole moment also increased for the same factor. Therefore, the decrease in the mean dielectric constant for the peptide in a membrane is mainly responsible for the increase in 3D HM and in the dipole moment. For the peptide immersed in the anionic membrane, both moments point toward the peptide Nterminal positioned at the inner membrane surface and are almost perfectly aligned with each other and with the peptide helical axis (not shown). This is likely to be important for peptide activity, because fast growing bacteria use its bioenergetics to separate charges and create a very strong inside directed electric field with electric field lines also pointing toward its cytoplasm [18] .
Discussion and conclusions
In retrospect, it is worthwhile to note that without having a clear idea of how to modify a peptide's helical arms, there was no a priori reason to believe that the modification of Ranatuerin-2CSa peptide by removing its Rana-box CKITGC would produce anything useful. The ranatuerin-2CSa with its Rana-box is already an excellent natural peptide antibiotic with broad-spectrum antibacterial activity and low toxicity (MIC = 4 to 5 μM against reference strain of E. coli, MIC = 10 μM against reference strain of S. aureus, and HC 50 = 150 to 160 μM [25, 80] ), and it has been repeatedly observed that deleting the Rana-box region can destroy peptide antibacterial activity [81, 82] . In our laboratory, we recently concluded that residues inside the Rana-box at the C-terminal of anuran peptides have a dominant antibacterial influence [26] .
The design procedure was greatly helped with a judicious use of our free-to-use algorithms for estimating and predicting high SI, low MIC, and sequential profile of α-helix amphipathicity for anuran-like antimicrobial peptides. It is the first example of a rational design using the composite parameter as the product of four terms, which are predicted activity (inverse MIC value), selectivity (HC 50 /MIC), and maximal amphipathicity for the N-terminal and C-terminal peptide segments.
Only one (S4 to K4) of 10 performed substitutions and deletions (after removing the Rana-box with its six residues) was suggested previously by Subasinhague et al. [25] . Other suggested substitutions K18, L16 or I16, A19 [25] , excluding those in the central GVAKGVAK segment, decreased amphipathicity of the C-terminal α-helical domain, predicted selectivity and activity, leading all together to diminished composite parameter.
Furthermore, we investigated why the central hinge TTR pattern GVAKGVAK in the pre-Rana-box domain is not just of interest as the peptide motif that can form the Möbius-like strip [26] , but also as the conserved motif in many ranatuerins. Formation of transient pores in the bacterial cytoplasmic membrane is not the only mechanism of how antimicrobial peptides can kill bacteria [15, 83] . However, it is a likely mechanism for the flexampin mode of action, because its design for flexible and adaptable structure did achieve a highly membrane-active peptide with a wide spectrum of bactericidal activity, but intracellular targets cannot be excluded for this peptide. The central hinge pattern in helical peptides may be responsible for cell-penetrating and antimicrobial activity as well [20] .
The tripartite flexampin structure consisting of a flexible TTR segment sandwiched between seven N-terminal and C-terminal residues, able to independently explore different helical conformations, provided this peptide with a unique chameleon-like capability for adjusting conformation to microenvironments. The presented MD simulations confirmed that the flexible middle segment facilitated the flexampin's entrance into the folding funnel from an almost perfect α-helix predicted by the QUARK ab initio algorithm into an ever more oblique helix all the way down to a molten globule state with a helical hairpin supersecondary structure in the presence of a neutral bilayer surface. The peptide can, however, distinguish anionic from neutral phospholipid surfaces interacting more strongly with the former.
A similar example is the TTR segment HVGKHVGK from pleurocidin, the antimicrobial peptide found in fish Pleuronectes americanus [84] . Recent MD study of pleurocidin showed that the conformational disorder in this central region of pleurocidin facilitates deeper entrance into the anionic membrane [7] . Both studies defined a TTR motif flexibility as the key feature for enhanced antibacterial potency.
We must stress, however, that due to the time restraint used in simulations, interpretation of the simulation data is at this stage indicative, and offer possible ideas on the mechanism of the peptidemembrane activity at the molecular level. Time constraint remains one of the challenges of in silico experiments, which, nevertheless, are remarkable in their capability to uncover the molecular details of the biological processes, traceable to biological or biophysical measurements. Some of the most successful examples are precisely membraneactive antimicrobial peptides, as elaborated in a recent article [85] . Flexampin adopted a partially helical amphipathic conformation with an elongated shape at the anionic membrane surface and asymmetric distribution of charges and hydrophobic surfaces associated with higher values of electrostatic dipole moment and 3D hydrophobic moment. The peptide moments, important for the interaction with bacterial-like and eukaryotic-like membrane, are very sensitive in orientation and magnitude to induced changes in structuring and decrease in solvent screening when the peptide is attracted toward the membrane, enabling positive feedback between an increase in 3D HM, increase in dipole moment, and deeper peptide entrance into the bacterial-like anionic bilayer. Helix formation at the anionic membrane surface and the concomitant increased surface concentration of antimicrobial peptides is a major driving force for peptide insertion into the phospholipid bilayer [86] . The selectivity observed during simulations can only be enhanced in the presence of the very strong electric field produced and maintained by metabolically active bacteria.
Indeed, the flexampin selectivity index confirms previous conclusions from MD simulations. Namely, a selectivity of SI = HC 50 / MIC(E. coli) = 670 is considerably higher in comparison to the best natural helical peptide from anurans [87] . MIC values range from 0.125 to 4.0 μM for the five standard and eight multidrug resistant bacteria strains we tested. In comparison with the designed peptide pexiganan, which has been the focus of pharmaceutical development for a very long time [88] , flexampin has much better selectivity and similar or stronger antibacterial activity. For instance, the peptide does not distinguish between standard and multidrug resistant A. baumannii strains, eliminating them all at MBC = 1 μM in vitro, which bodes well for possible topical applications. However, the real potential of flexampin remains unknown before it is tested in more stringent conditions and in vivo models. The source of low but significant peptide toxicity to human cells at concentrations not much higher from bactericidal concentrations also remains unknown. Together with the suggested analogues, this new class of linear flexible peptide antibiotics merits investigation of their pore-forming or cell-penetrating abilities leading to antibacterial and possibly antifungal, antiprotozoal, and anticancer activities as well.
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